Utama › Limfoma Folikular
Kajian klinikal Limfoma Folikular sedang mengambil peserta di AS
107 kajian untuk Limfoma Folikular sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY24 kajian
- Milwaukee, WI19 kajian
- Houston, TX18 kajian
- Nashville, TN18 kajian
- Boston, MA17 kajian
- Baldwin Park, CA16 kajian
- Seattle, WA15 kajian
- Durham, NC15 kajian
- Columbus, OH13 kajian
- Salt Lake City, UT13 kajian
- Chicago, IL12 kajian
- Philadelphia, PA12 kajian
- San Antonio, TX12 kajian
- Dallas, TX11 kajian
- Denver, CO11 kajian
- Los Angeles, CA11 kajian
- Atlanta, GA11 kajian
- Washington, DC11 kajian
- Edison, NJ11 kajian
- Rochester, MN10 kajian
- Jacksonville, FL10 kajian
- Portland, OR9 kajian
- Cincinnati, OH9 kajian
- Cleveland, OH9 kajian
- New Haven, CT9 kajian
- Pittsburgh, PA8 kajian
- San Diego, CA8 kajian
- Miami, FL8 kajian
- San Francisco, CA8 kajian
- Charlotte, NC7 kajian
- Tampa, FL7 kajian
- Clifton, NJ7 kajian
- St. Louis, MO7 kajian
- Mountain View, CA7 kajian
- Queens, NY7 kajian
- Cedar Rapids, IA7 kajian
- Austin, TX6 kajian
- Greenburgh, NY6 kajian
- Winston-Salem, NC6 kajian
- Buffalo, NY5 kajian
Mengikut negeri
- Alabama5 kajian
- Arizona11 kajian
- Arkansas3 kajian
- California36 kajian
- Colorado14 kajian
- Connecticut10 kajian
- Delaware4 kajian
- Florida25 kajian
- Georgia15 kajian
- Illinois14 kajian
- Indiana7 kajian
- Iowa9 kajian
- Kansas7 kajian
- Kentucky10 kajian
- Louisiana8 kajian
- Maryland9 kajian
- Massachusetts20 kajian
- Michigan12 kajian
- Minnesota18 kajian
- Mississippi4 kajian
- Missouri9 kajian
- Nebraska4 kajian
- New Jersey15 kajian
- New Mexico3 kajian
- New York30 kajian
- North Carolina23 kajian
- Ohio23 kajian
- Oklahoma4 kajian
- Oregon11 kajian
- Pennsylvania17 kajian
- Rhode Island4 kajian
- South Carolina6 kajian
- Tennessee19 kajian
- Texas35 kajian
- Utah13 kajian
- Virginia9 kajian
- Washington19 kajian
- Wilayah Columbia4 kajian
- Wisconsin21 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03460977Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07215910Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Mengambil pesertaKajian pemerhatian
Umur 0 hingga 38 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT061318015HTP Regulation Of Asthma In Children
Mengambil pesertaFasa 2
Umur 8 hingga 18 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT04160910Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07631598A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06542250A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05006716Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06350318A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07634471A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07519772Epco, Zanu, Ritux for R/R FL or MZL
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06563596Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06784167A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07226843Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06453044A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Mengambil pesertaFasa 3
Umur 18 hingga 130 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06549595huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07343934NEO100 and High-Grade Meningioma
Mengambil pesertaFasa 2
Umur 12 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05023018Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Mengambil pesertaFasa 3
Umur 12 hingga 100 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06091254Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07225439A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06043323A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Mengambil pesertaKajian pemerhatian
Umur 0 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07154823Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.